Fox News medical contributor Dr. Nicole Saphier reacts to the Trump administration's plans to take on the fentanyl crisis on 'The Story.' A new opioid-free pain medication was approved by the U.
S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex, is the "first and only approved non-opioid oral pain signal inhibitor," according to a press release from the Massachusetts-based company.
The new drug is intended for treatment of moderate to severe acute pain in adults. COMMON PAIN RELIEVER COULD CAUSE MEDICAL COMPLICATIONS IN SOME PEOPLE OVER 65, STUDY SUGGESTS Importance of a non-opioid alternative Patients with acute pain after surgery or due to a broken bone or an injury are often prescribed opioid medications , according to Julie Pilitsis, MD, PhD, a neurosurgeon at Banner – University Medicine and chair of the Department of Neurosurgery at the University of Arizona College of Medicine in Tucson. A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
(iStock) "This is the first time many patients receive opioids, and a subset of patients are known to go on to become dependent or addicted to the medications," she told Fox News Digital. "Patients with pain have had very few options to treat their pain with medications that don’t have addictive properties or side effects they can’t tolerate." THE 6 MOST COMMON HEADACHE TYP.
